Lifecore Biomedical Inc.

07/24/2024 | Press release | Distributed by Public on 07/24/2024 14:20

Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.
On July 18, 2024, the Board of Directors (the "Board") of Lifecore Biomedical, Inc. (the "Company") approved a cash incentive award plan for the Company's fiscal year 2025 ending May 25, 2025 (the "2025 Annual Incentive Plan"), which was recommended by the Compensation Committee of the Board.
Under the 2025 Annual Incentive Plan, executive officers and other participants are eligible to earn cash bonuses based on the Company's adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") and four business objectives, weighted at 80% and 20%, respectively. The four business objectives are a combination of sustaining and growth objectives each weighted equally at 5%. Adjusted EBITDA for purposes of the 2025 Annual Incentive Plan will be based on the Company's fiscal year 2025 Adjusted EBITDA which excludes changes in the fair value of debt derivatives, financing fees, restructuring and reorganization costs, state franchise taxes, amounts paid in settlement of governance matters, and stock based compensation expense, but includes the cost of bonuses under the 2025 Annual Incentive Plan.
Under the 2025 Annual Incentive Plan, the Board also set based upon the recommendation of the Compensation Committee the minimum, target and maximum level of achievement of Adjusted EBITDA. Achievement of Adjusted EBITDA at greater or less than target level will result in increasing or decreasing incentive pay relating to that performance goal based upon a Board-approved scale. Additionally, if minimum fiscal year 2025 Adjusted EBITDA is not achieved, no amounts will be earned under the 2025 Annual Incentive Plan. The maximum cash incentive pay that may be earned under the 2025 Annual Incentive Plan by an executive officer or any other participant will not exceed 200% of that person's opportunity at the target level, even if actual performance exceeds the maximum level for Adjusted EBITDA or any of the sustaining or growth objectives.
The Board also approved, based upon the recommendation of the Compensation Committee, the cash incentive pay that the Company's executive officers may earn under the 2025 Annual Incentive Plan at the target level of achievement as a percentage of their respective annual base salaries as follows: Paul Josephs and John D. Morberg, 100% and 60%, respectively.
All payments to the executive officers under the 2025 Annual Incentive Plan are subject to "clawback" under the Company's Compensation Recoupment Policy adopted effective October 2, 2023.